Myelin protein zero mutation in Charcot-Marie-Tooth Disease

Lorance DK, Mandigo KA, Hehir MK. Novel Myelin Protein Zero Mutation in 3 Generations of Vermonters With Demyelinating Charcot-Marie-Tooth Disease. J Clin Neuromuscul Dis. 2018 Mar;19(3):101-107.

Abstract

OBJECTIVES:

We report the clinical phenotype in 3 consecutive generations with demyelinating Charcot-Marie-Tooth disease that possess a novel sequence variant of myelin protein zero (MPZ).

METHODS:

Family members from 3 consecutive generations were interviewed, examined, and studied with electrodiagnostic testing. Commercially available next-generation sequencing was performed for the proband. Single-gene analysis was performed for the remaining family members.

RESULTS:

All patients demonstrated symmetric distal weakness; symmetric distal sensory loss; and diminished deep tendon reflexes. Electrodiagnostic testing was consistent with primary distal demyelination with secondary axon loss. Genetic testing identified a novel base-pair substitution of MPZ (c.314C>T), resulting in a missense variant (p.Pro105Leu).

CONCLUSIONS:

The novel MPZ base-pair substitution in this family is associated with inherited distal demyelinating neuropathy and should be reclassified as pathogenic for Charcot-Marie-Tooth.

https://journals.lww.com/jcnmd/Fulltext/2018/03000/Novel_Myelin_Protein_Zero_Mutation_in_3.1.aspx?cid=2018-MEDPR-AdSales-Spotlight-%20Neurology-AlexionSoliris.02-SEND-2493&rid=V_0000000032999587&mkt_tok=eyJpIjoiWlRNd05qRXhNV0pqTWpReSIsInQiOiJLZld4cW1STit3TE1FYXpUVklRbE9UdUVqUWV3NVgxTjZuSTRZM0RqRTM2QkRwT0l1M3NsWGYzaGZ2U210RW40bGZVa1hTMnVPT2NTYStJaU1EOTJTRzVET1pFalR0TVU1TGNSVmFvK0RkZWplKzJrMFdBR3Vsd1VPRU8zS3RpayJ9